Gerald Durrell’s Centenary: a year of celebrations starts today
January 10, 2025
Zebra dies after ‘incident’with rhino at zoo
January 10, 2025
The FINANCIAL -- Sanofi and Regeneron Pharmaceuticals, Inc. on October 5 announced that the U.S. Court of Appeals for the...
The FINANCIAL -- Eli Lilly and Company on October 5 announced that the Patent Trial and Appeal Board of the...
The FINANCIAL -- Gilead Sciences, Inc. on October 3 announced the successful completion of the tender offer by its wholly-owned...
The FINANCIAL -- Johnson & Johnson on October 3 announced the completion of the divestiture of its Codman Neurosurgery business...
The FINANCIAL -- Allergan plc on October 2 announced the U.S. Food and Drug Administration (FDA) has accepted a supplemental...
The FINANCIAL -- Eli Lilly and Company on September 29 announced a number of leadership changes, promoting several experienced Lilly...
The FINANCIAL -- Roche on September 29 announced the US Food and Drug Administration (FDA) has accepted the company’s supplemental...
The FINANCIAL -- Bayer has definitively ceded control of Covestro AG. Through the sale of a further 6.9 percent of...
The FINANCIAL -- AbbVie on September 27 announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved MAVIRET...
The FINANCIAL -- Sanofi and Regeneron Pharmaceuticals, Inc. on September 28 announced that the European Commission has granted marketing authorization...
The FINANCIAL -- Novo Nordisk on September 27 announced that the China Food and Drug Administration (CFDA) has approved Tresiba...
The FINANCIAL -- GSK announced on September 27 that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved...
The FINANCIAL -- Gilead Sciences, Inc. announced on September 25 that the China Food and Drug Administration (CFDA) has approved...
The FINANCIAL -- Roche announced on September 22 that the European Commission (EC) has approved Actemra/RoActemra (tocilizumab) for the treatment...
The FINANCIAL -- Roche announced on September 22 that the European Commission has approved Gazyvaro (obinutuzumab) in combination with chemotherapy,...